Buy-rated picks in these sectors include Amgen ( AMGN ), Gilead Sciences ( GILD ), Moderna ( MRNA ), and United Therapeutics ( UTHR) for biotech, and Alcoa ( AA ), Freeport-McMoRan ( FCX ), MP ...

Rallybio stock jumps after announcing a $505 million merger with Candid Therapeutics, boosting cash to $700 million.

CRVS stock surged more than 200% in early 2026 as investors repriced its oral ITK inhibitor opportunity. Erasca Inc (ERAS) secured $258.8 million in fresh capital and holds patent protection on ...

Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best cheap biotech stocks to buy now. Jazz Pharmaceuticals (NASDAQ:JAZZ) was ...

In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now.

Genenta Science SPA (NASDAQ:GNTA) is among the best Italian stocks to buy in 2026. Genenta Science SPA (NASDAQ:GNTA) will hold an extraordinary shareholders meeting on March 26. This comes on the back ...

Eli Casdin, Casdin Capital CEO, joins 'Closing Bell' to discuss the biotech sector, the stocks Casdin favors and much more.

In the throes of a "bearish-to-bullish" reversal, the stock exhibits bullish price-volume correlation and impressive relative strength to the market and to other biotechnology stocks. We're buyers ...

Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market volatility kept investors ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a ...

Generate Biomedicines has announced the pricing of its initial public offering, implying a market value of about $2 billion for the U.S. biotechnology firm. The company, which specializes in designing ...

The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest new stock offering in nearly three years.